Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

A Multicenter Comparison Study Between the Endosafe ® PTS™ Rapid-Release Testing System and Traditional Methods for Detecting Endotoxin in Cell-Therapy Products

Go back to Resources

A Multicenter Comparison Study Between the Endosafe ® PTS™ Rapid-Release Testing System and Traditional Methods for Detecting Endotoxin in Cell-Therapy Products

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Visual Acuity Loss Associated With Advanced AMD Fundus Lesions and With the Simplified AREDS AMD Severity Scale

Go back to Resources

Visual Acuity Loss Associated With Advanced AMD Fundus Lesions and With the Simplified AREDS AMD Severity Scale

Authors:

Secondary:

Location:

Go back to Resources

Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases

Go back to Resources

Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Use of rhGH in Children with Chronic Kidney Disease: Lessons from NAPRTCS

Go back to Resources

Use of rhGH in Children with Chronic Kidney Disease: Lessons from NAPRTCS

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Role of Practice Based Research Networks (PBRN) in the Spectrum of Clinical Trials

Go back to Resources

The Role of Practice Based Research Networks (PBRN) in the Spectrum of Clinical Trials

Authors:

Go back to Resources

The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 20

Go back to Resources

The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 20

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22

Go back to Resources

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The NCI Pediatric Central Institutional Review Board (PedCIRB) Initiative: Progress and Impact

Go back to Resources

The NCI Pediatric Central Institutional Review Board (PedCIRB) Initiative: Progress and Impact

Authors:

Secondary:

Volume:

Publisher:

Abstract:

Go back to Resources

The National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC)

Go back to Resources

The National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC)

Authors:

Secondary:

Location:

Go back to Resources

Motor Function and Human Immunodeficiency Virus-Associated Cognitive Impairment in a Highly Active Antiretroviral Therapy-Era Cohort

Go back to Resources

Motor Function and Human Immunodeficiency Virus-Associated Cognitive Impairment in a Highly Active Antiretroviral Therapy-Era Cohort

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 163
  • Page 164
  • Page 165
  • Page 166
  • Current page 167
  • Page 168
  • Page 169
  • Page 170
  • Page 171
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions